ProfileGDS4718 / 1557227_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 4% 63% 43% 24% 25% 63% 67% 33% 16% 21% 11% 40% 57% 64% 65% 13% 12% 55% 65% 74% 54% 33% 17% 4% 41% 55% 10% 60% 22% 43% 43% 62% 49% 11% 59% 68% 51% 41% 41% 64% 8% 24% 41% 70% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.534654
GSM549102patient 115, normal, homogenized [OPG study]6.3362763
GSM549104patient 119, normal, homogenized [OPG study]5.1454343
GSM549108patient 138, normal, homogenized [OPG study]4.3544824
GSM549119patient 077, normal, homogenized [OPG study]4.3609725
GSM549133patient 032, cancer, homogenized [OPG study]6.3709463
GSM549139patient 042, cancer, homogenized [OPG study]6.6652767
GSM549099patient 107, normal, homogenized [OPG study]4.7004333
GSM549109patient 139, normal, homogenized [OPG study]4.0082716
GSM549110patient 046, normal, homogenized [OPG study]4.1796521
GSM549114patient 063, normal, homogenized [OPG study]3.8043911
GSM549122patient 082, normal, homogenized [OPG study]5.0083440
GSM549134patient 033, cancer, homogenized [OPG study]5.8829457
GSM549136patient 036, cancer, homogenized [OPG study]6.4382964
GSM549140patient 044, cancer, homogenized [OPG study]6.4543765
GSM549111patient 047, normal, homogenized [OPG study]3.8773813
GSM549113patient 057, normal, homogenized [OPG study]3.7977612
GSM549132patient 031, cancer, homogenized [OPG study]5.7955455
GSM549137patient 038, cancer, homogenized [OPG study]6.475265
GSM549142patient 047, cancer, homogenized [OPG study]7.1472674
GSM549100patient 110, normal, homogenized [OPG study]5.7457554
GSM549107patient 135, normal, homogenized [OPG study]4.6387333
GSM549115patient 068, normal, homogenized [OPG study]3.9828617
GSM549116patient 072, normal, homogenized [OPG study]3.561344
GSM549120patient 078, normal, homogenized [OPG study]5.0236341
GSM549131patient 030, cancer, homogenized [OPG study]5.7841855
GSM549118patient 074, normal, homogenized [OPG study]3.800610
GSM549129patient 027, cancer, homogenized [OPG study]6.162360
GSM549123patient 088, normal, homogenized [OPG study]4.218722
GSM549124patient 006, cancer, homogenized [OPG study]5.1689543
GSM549126patient 015, cancer, homogenized [OPG study]5.1254543
GSM549128patient 025, cancer, homogenized [OPG study]6.3186662
GSM549103patient 117, normal, homogenized [OPG study]5.5023749
GSM549117patient 073, normal, homogenized [OPG study]3.8142111
GSM549138patient 041, cancer, homogenized [OPG study]6.0962659
GSM549141patient 045, cancer, homogenized [OPG study]6.7927568
GSM549130patient 028, cancer, homogenized [OPG study]5.5480251
GSM549101patient 111, normal, homogenized [OPG study]5.0705241
GSM549105patient 128, normal, homogenized [OPG study]5.0802341
GSM549106patient 134, normal, homogenized [OPG study]6.4531964
GSM549112patient 048, normal, homogenized [OPG study]3.702198
GSM549125patient 011, cancer, homogenized [OPG study]4.3201724
GSM549127patient 024, cancer, homogenized [OPG study]5.0294841
GSM549135patient 035, cancer, homogenized [OPG study]6.8838770